Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?

Core Viewpoint - Hims & Hers Health, Inc. has experienced significant stock price decline and is currently under scrutiny for its future performance, with key factors influencing its stock being earnings estimates and revenue growth [1][2]. Earnings Estimate Revisions - Hims & Hers Health is expected to report earnings of $0.14 per share for the current quarter, reflecting a year-over-year increase of +180% [5]. - The Zacks Consensus Estimate for the current fiscal year is $0.72, indicating a year-over-year change of +166.7%, with a recent increase of +13.4% over the last 30 days [5]. - For the next fiscal year, the consensus earnings estimate is $1.07, representing a +48.4% change from the previous year, with a +12.5% increase in the estimate over the past month [6]. - The Zacks Rank for Hims & Hers Health is 2 (Buy), indicating a positive outlook based on earnings estimate revisions [7]. Projected Revenue Growth - The consensus sales estimate for the current quarter is $537.85 million, showing a year-over-year increase of +93.4% [11]. - For the current fiscal year, the revenue estimate is $2.33 billion, indicating a +58% change, while the next fiscal year's estimate is $2.84 billion, reflecting a +21.6% change [11]. Last Reported Results and Surprise History - In the last reported quarter, Hims & Hers Health generated revenues of $481.14 million, a year-over-year increase of +95.1%, with an EPS of $0.11 compared to $0.01 a year ago [12]. - The company exceeded consensus revenue estimates in all four of the last quarters, surpassing EPS estimates twice during this period [13]. Valuation - Hims & Hers Health is graded B in the Zacks Value Style Score, indicating it is trading at a discount compared to its peers [17].